Urinary Tract Infection (UTI)

Definition

  1. Asymptomatic bacteriuria: Urine bacterial growth >= 10^5 cfu/mL in 2 serial samples in women or a single sample in man without UTI symptoms 
  2. Uncomplicated UTI: Acute, sporadic or recurrent lower (uncomplicated cystitis) &/or upper (uncomplicated pyelonephritis) UTI, limited to non-pregnant women with no known relevant anatomical & functional abnormalities within the urinary tract or comorbidities 
  3. Complicated UTI – UTI with increased risk of a complicated course:
    • All men 
    • Pregnant women 
    • Anatomical or functional abnormalities of the urinary tract 
    • Indwelling urinary catheters 
    • Renal diseases 
    • Concomitant immunocompromising diseases (e.g. uncontrolled DM) 
  4. Catheter-associated UTI (CAUTIs): UTI in a person who is currently catheterized or has had a catheter in place within the past 48 hours. 
  5. Urosepsis: Sepsis secondary to infection originating from the urinary tract 
  6. Recurrent UTI: Recurrence of uncomplicated &/or complicated UTIs, at least 3 ep./year or 2 UTIs in the last 6 months. 
  7. Upper UTI: Involves the ureters (ureteritis) and kidneys (pyelonephritis)
  8. Lower UTI: Infection of the bladder (cystitis)

Asymptomatic bacteriuria (ABU)

Men & non-pregnant women with asymptomatic bacteriuria should not be started on antibiotics. 

Antibiotics should only be prescribed for ABU in 2 conditions:

  1. Pregnancy 
  2. Prior to urological procedures where there is possibility of mucosal breaching 

This is consistent with the EAU guidelines. 

Do not screen or treat ABU in the following conditions:

  • Women without risk factors 
  • Post-menopausal women 
  • Patients with indwelling or suprapubic catheters & nephrostomy tube 
  • Elderly institutionalized patients 
  • Patients with dysfunctional &/or reconstructed lower urinary tracts 
  • Patients with renal transplants 
  • Patients prior to arthroplasty surgeries 
  • Patients with h/o recurrent UTI 

Common organisms involved

  • Escherichia coli 
  • Klebsiella pneumoniae 
  • Streptococcus agalactiae (Group B streptococcus) – significant to treat in pregnant women 
  • Coagulase-negative staphylococcus 
  • S. aureus 

UTI risk factors

General UTI symptoms

  • Dysuria (pain, burning, stinging) 
  • Urgency  
  • Frequency 
  • Incontinence 
  • Urethral purulence 
  • Pressure or cramping in the lower abdomen 
  • +/- Systemic SSx of infection: Fever, Sepsis features (in urosepsis), etc. 

The UK guideline has indicated there are 3 key urinary symptoms: Dysuria, New nocturia and cloudy urine. 

Warning signs that require further assessment & management include: pyelonephritis (flank pain, fever with chills and rigors, nausea or vomiting), sepsis, cancer.

It is important to rule out genitourinary causes urinary symptoms in women.  

  • Vaginal infection: Enquire regarding vaginal discharge or vaginal irritation 
  • Urethritis (post sexual intercourse, irritants, or sexually transmitted infection). It is important to rule out sexual transmitted diseases (by assessing for any high risk behavior), if not opportunities might be missed to diagnose & treat STI. [This point applies to both male & female patients]
  • Genitourinary symptoms of menopause/atrophic vaginitis/vaginal atrophy 

Approach to suspected UTI in Adults, Non-pregnant

Severe symptoms (patient has >= 3 symptoms suggestive of UTI). These symptoms include:

  • Dysuria
  • Urgency
  • Frequency
  • Loin pain/suprapubic pain
  • Polyuria
  • Worsening incontinence
  • Hematuria

This algorithm has also provided a guide to approach urinalysis with either nitrite or leucocyte positive which is often encountered in daily clinical practice.

Management

Further comments

Ciprofloxacin & other fluoroquinolones are highly efficacious in 3-day regimens but have risk of collateral damage, thus should be reserved for: 

  • Definitive therapy or severe infections 
  • Those who cannot tolerate the recommended antibiotics either due to adverse effects or allergy 

Trimethoprim-sulfamethoxazole is not recommended as empirical therapy due to local resistance rate or E.coli & Klebsiella pneumoniae has been consistently > 30%. If indicated/susceptible, can start 160/800 mg BD for 3 days 

Amoxicillin or ampicillin should not be used empirical treatment due to relatively poor efficacy and prevalence of antimicrobial resistance. 

NICE guidelines recommendation on duration of antibiotic treatment for UTI :

Non-pregnant women with uncomplicated lower UTI: 3 days 

Men and pregnant women with uncomplicated lower UTI: 7 days 

Patients started on antibiotic should be reassessed if symptoms worsen rapidly, or shows no improvement within 48 hours of taking the antibiotic. 

Regarding Catheter-associated UTI (CA-UTI)

In adults with indwelling urinary catheter, urine dipstick is not reliable to detect UTI as catheters can quickly become colonised with bacteria resulting in a positive dipstick result. 

In these group of patients, signs & symptoms are assessed to diagnose UTIs with urine C&S used to support the diagnosis & guide treatment. 

Pyuria alone in otherwise asymptomatic patient is not diagnostic of CA-UTI. Whenever indicated, change catheter prior to starting treatment. 

For mild or moderate CAUTIs, where patient is stable with no signs of systemic infection, oral antibiotics may be sufficient. The choice between oral & IV antibiotics should be guided by clinical judgement, patient’s overall condition, & results of urine C&S. 

Similar Posts

  • Screening for Anxiety and Depression

    When to call it a disorder? Characterized by a clinically significant disturbance in an individual’s cognition, emotional regulation, or behaviour.Usually associated with distress or impairment in important areas of functioning (functional impairment).Duration also have to be taken into consideration. 🔍Screening tools DASS score Used for screening of depression, anxiety and stress. Once patient is suspected…

  • Insomnia

    Definition Persistent difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity and circumstances for sleep, resulting in some form of daytime impairment. Neurotransmitters involved in sleep Understanding the different neurotransmitter involved can help us to understand the different pharmacological treatment.  Sleep-inducing (inhibiting wakefulness): Adenosine, Nitric oxide, GABA Sleep-preventing (triggering wakefulness): Glutamate,…

  • MAFLD/MASLD

    Terminologies In recent years, there has been a shift in terminologies from Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic-dysfunction Associated Fatty Liver Disease (MAFLD) and the latest Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)  This shift in terminology is a reflect of the underlying pathophysiology whereby metabolic dysfunction has been shown to link with liver disease…

  • |

    H. pylori

    Helicobacter pylori (H. pylori) is a gram negative, flagellated, spiral bacteria that primarily colonizes the stomach and is largely responsible for gastric and or duodenal ulcers. It is also a class I carcinogen that may increase one’s risk of gastric carcinoma. Transmission of H. pylori is thought to be via fecal-oral, oral-oral and may include…

  • Breast Cancer Screening

    Risk category Women are generally evaluated for their risk of breast cancer, which helps determine the appropriate screening protocol. Risk category can be divided into: A. General population These are women with: B. Individuals with high risk of developing breast cancer 🚨 These are women who fulfilled any one of the below: This risk stratification…

Leave a Reply

Your email address will not be published. Required fields are marked *